Date: 02-01-2012
0112 E3002
Second Year MBBS Examination
II MBBS Pharmacology Paper 1
Time: 2 hours
1. Answer to the points.
2. Figure to the right indicates marks.
3. Use separate answer books for each section.
4. Draw diagrams wherever necessary.
Section 1
1. Give an account of any TWO of the following
(10)
a) Define bioavailability. Explain the
bioavailability. (A.16,8. 12)
b) Explain the mechanism of action, clinical
uses and adverse effects of Mannitol. (A. 590,
. 550)
uses and adverse effects of Sodium valproate.
(A. 417,131)
2. Write Short notes of (any three)
(12)
(A. 146, . 277)
b) List important differences between
Barbiturates and Benzodiazepines (A. 401, B.
109)
Blockers (A. 550, B. 400)
d) Explain the clinical uses of reversible
Anticholinesterases (A. 108, . 287)
3. Discuss Any Three
a) Explain the clinical uses of Aspirin (A. 198,
B. 169)
b) Explain the management of status
asthmaticus (A. 233, B. 364)
analogues (A. 189, B. 343)
d) Management of alcohol addicts (A. 393, B.
90)
4. Write Answer to the point in two or three
sentences: (any six)
(6)
a) Define pharmacogenetics with two
examples. (A. 65, . 58)
b) Mention two alpha 1(a1) receptor stimulants
c) Mention two atypical antipsychotic drugs
and write two advantages. (A. 441, . 195)
d) Explain the basis for using scopolamine in
motion sickness. (A. 113, B. 296)/Scopolamine
motion sickness.
e) Mention two uses and two specific adverse
effects of Nitroglycerine. (A. 542, . 436)
f) Explain the basis for combining
g) Explain the basis for using Lignocaine in
ventricular tachy-arrhythmias. (A. 530, B. 381)
h) Mention two types of receptor antagonism
with one example for each. (A. 58, 38)
0112 E3002
Second Year MBBS Examination
II MBBS Pharmacology Paper 1
Time: 2 hours
--- Content provided by FirstRanker.com ---
Max Marks: 401. Answer to the points.
2. Figure to the right indicates marks.
3. Use separate answer books for each section.
4. Draw diagrams wherever necessary.
--- Content provided by FirstRanker.com ---
5. Write legibly.Section 1
1. Give an account of any TWO of the following
(10)
a) Define bioavailability. Explain the
--- Content provided by FirstRanker.com ---
patient (biological) factors affectingbioavailability. (A.16,8. 12)
b) Explain the mechanism of action, clinical
uses and adverse effects of Mannitol. (A. 590,
. 550)
--- Content provided by FirstRanker.com ---
c) Explain the mechanism of action, clinicaluses and adverse effects of Sodium valproate.
(A. 417,131)
2. Write Short notes of (any three)
(12)
--- Content provided by FirstRanker.com ---
a) Explain the contraindications of propranolol(A. 146, . 277)
b) List important differences between
Barbiturates and Benzodiazepines (A. 401, B.
109)
--- Content provided by FirstRanker.com ---
c) List the clinical uses of calcium channelBlockers (A. 550, B. 400)
d) Explain the clinical uses of reversible
Anticholinesterases (A. 108, . 287)
3. Discuss Any Three
--- Content provided by FirstRanker.com ---
(12)a) Explain the clinical uses of Aspirin (A. 198,
B. 169)
b) Explain the management of status
asthmaticus (A. 233, B. 364)
--- Content provided by FirstRanker.com ---
c) Explain the clinical uses of Prostaglandinanalogues (A. 189, B. 343)
d) Management of alcohol addicts (A. 393, B.
90)
4. Write Answer to the point in two or three
--- Content provided by FirstRanker.com ---
sentences: (any six)
(6)
a) Define pharmacogenetics with two
examples. (A. 65, . 58)
b) Mention two alpha 1(a1) receptor stimulants
--- Content provided by FirstRanker.com ---
and write two clinical uses. (A. 135, B. 257)c) Mention two atypical antipsychotic drugs
and write two advantages. (A. 441, . 195)
d) Explain the basis for using scopolamine in
motion sickness. (A. 113, B. 296)/Scopolamine
--- Content provided by FirstRanker.com ---
is preferred over atropine for treatment ofmotion sickness.
e) Mention two uses and two specific adverse
effects of Nitroglycerine. (A. 542, . 436)
f) Explain the basis for combining
--- Content provided by FirstRanker.com ---
Hydrochlorothiazide with Ramipril. (A. 504)g) Explain the basis for using Lignocaine in
ventricular tachy-arrhythmias. (A. 530, B. 381)
h) Mention two types of receptor antagonism
with one example for each. (A. 58, 38)
--- Content provided by FirstRanker.com ---